Engineered biosynthetic pathway for sialic acid analogs and its use for the development of anti-infectives
There is clearly an unmet need for anti-influenza drugs that are more effective than those currently available, and ideally that are effective against various strains of influenza and that are not prone to the development of resistance. The unique features of the NRC-IBS technology, with its anticip...
Main Authors: | , |
---|---|
Format: | Other/Unknown Material |
Language: | English |
Published: |
National Research Council of Canada
2010
|
Subjects: | |
Online Access: | https://nrc-publications.canada.ca/eng/view/ft/?id=0c36bca9-da1a-48cd-9eff-b526aceb2556 https://nrc-publications.canada.ca/eng/view/object/?id=0c36bca9-da1a-48cd-9eff-b526aceb2556 https://nrc-publications.canada.ca/fra/voir/objet/?id=0c36bca9-da1a-48cd-9eff-b526aceb2556 |
id |
ftnrccanada:oai:cisti-icist.nrc-cnrc.ca:cistinparc:17442572 |
---|---|
record_format |
openpolar |
spelling |
ftnrccanada:oai:cisti-icist.nrc-cnrc.ca:cistinparc:17442572 2023-05-15T15:34:21+02:00 Engineered biosynthetic pathway for sialic acid analogs and its use for the development of anti-infectives Schoenhofen, Ian Whitfield, Dennis M. 2010-05-01 text 1 p. https://nrc-publications.canada.ca/eng/view/ft/?id=0c36bca9-da1a-48cd-9eff-b526aceb2556 https://nrc-publications.canada.ca/eng/view/object/?id=0c36bca9-da1a-48cd-9eff-b526aceb2556 https://nrc-publications.canada.ca/fra/voir/objet/?id=0c36bca9-da1a-48cd-9eff-b526aceb2556 eng eng National Research Council of Canada The Crossroad for Biotransfer 2010, The Crossroad for Biotransfer 2010, May 18, 2010, Boston, Massachusetts, United States, Publication date: 2010-05-01 address 2010 ftnrccanada 2022-07-30T23:00:51Z There is clearly an unmet need for anti-influenza drugs that are more effective than those currently available, and ideally that are effective against various strains of influenza and that are not prone to the development of resistance. The unique features of the NRC-IBS technology, with its anticipated efficacy against numerous strains, possibly including avian flu, will enable it to compete effectively against such products. We also note that the market is quite large, and is likely to continue to grow over the coming years. The technology may also result in the development of agents against other viral infections, and against bacterial infections. Peer reviewed: Yes NRC publication: Yes Other/Unknown Material Avian flu National Research Council Canada: NRC Publications Archive |
institution |
Open Polar |
collection |
National Research Council Canada: NRC Publications Archive |
op_collection_id |
ftnrccanada |
language |
English |
description |
There is clearly an unmet need for anti-influenza drugs that are more effective than those currently available, and ideally that are effective against various strains of influenza and that are not prone to the development of resistance. The unique features of the NRC-IBS technology, with its anticipated efficacy against numerous strains, possibly including avian flu, will enable it to compete effectively against such products. We also note that the market is quite large, and is likely to continue to grow over the coming years. The technology may also result in the development of agents against other viral infections, and against bacterial infections. Peer reviewed: Yes NRC publication: Yes |
format |
Other/Unknown Material |
author |
Schoenhofen, Ian Whitfield, Dennis M. |
spellingShingle |
Schoenhofen, Ian Whitfield, Dennis M. Engineered biosynthetic pathway for sialic acid analogs and its use for the development of anti-infectives |
author_facet |
Schoenhofen, Ian Whitfield, Dennis M. |
author_sort |
Schoenhofen, Ian |
title |
Engineered biosynthetic pathway for sialic acid analogs and its use for the development of anti-infectives |
title_short |
Engineered biosynthetic pathway for sialic acid analogs and its use for the development of anti-infectives |
title_full |
Engineered biosynthetic pathway for sialic acid analogs and its use for the development of anti-infectives |
title_fullStr |
Engineered biosynthetic pathway for sialic acid analogs and its use for the development of anti-infectives |
title_full_unstemmed |
Engineered biosynthetic pathway for sialic acid analogs and its use for the development of anti-infectives |
title_sort |
engineered biosynthetic pathway for sialic acid analogs and its use for the development of anti-infectives |
publisher |
National Research Council of Canada |
publishDate |
2010 |
url |
https://nrc-publications.canada.ca/eng/view/ft/?id=0c36bca9-da1a-48cd-9eff-b526aceb2556 https://nrc-publications.canada.ca/eng/view/object/?id=0c36bca9-da1a-48cd-9eff-b526aceb2556 https://nrc-publications.canada.ca/fra/voir/objet/?id=0c36bca9-da1a-48cd-9eff-b526aceb2556 |
genre |
Avian flu |
genre_facet |
Avian flu |
op_relation |
The Crossroad for Biotransfer 2010, The Crossroad for Biotransfer 2010, May 18, 2010, Boston, Massachusetts, United States, Publication date: 2010-05-01 |
_version_ |
1766364775782023168 |